Workflow
This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy.
百时美施贵宝百时美施贵宝(US:BMY) Barrons·2025-11-20 21:00

Bristol Myers Squibb trades at seven times earnings, with multiple growth drivers. ...